Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 Mpro)-Reference-Cited by-同舟云学术

Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 Mpro)

Published:2023-09 Issue: Volume:257 Page:115487
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhang Kuojun,Wang Tianyu,Li Maotian,Liu Mu,Tang He,Wang Lin,Ye Ke,Yang Jiamei,Jiang Sheng,Xiao Yibei,Xie Youhua,Lu Meiling,Zhang Xiangyu^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference44 articles.

1. WHO, WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/(accessed date: 2022.December.14).

2. Hundreds of COVID trials could provide a deluge of new drugs;Ledford;Nature,2022

3. A comprehensive review of the global efforts on COVID-19 vaccine development;Li;ACS Cent. Sci.,2021

4. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact;Lipsitch;Nat. Rev. Immunol.,2022

5. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet (London, England),2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Basis of Main Proteases of Coronavirus Bound to Bofutrelvir;Journal of Molecular Biology;2024-11

2. Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (M^pro);ACS Omega;2024-08-02

3. Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry;Bioorganic & Medicinal Chemistry;2024-07

4. Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review;Bioorganic Chemistry;2024-06

5. Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2;Future Medicinal Chemistry;2024-04-15